Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGKA | P23743 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 3/20 | 0.47 |
| ▸ | PAM | P19021 | 2/20 | 0.46 |
| ▸ | CES2 | O00748 | 4/20 | 0.44 |
| ▸ | CES1 | P23141 | 4/20 | 0.44 |
| ▸ | MAPT | P10636 | 3/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.43 |
| ▸ | CNR2 | P34972 | 1/20 | 0.42 |
| ▸ | GMNN | O75496 | 1/20 | 0.42 |
| ▸ | USP2 | O75604 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | APEX1 | P27695 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | RECQL | P46063 | 1/20 | 0.42 |
| ▸ | BLM | P54132 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4890997 | 0.98 | DGKA (0.53) | DGKATSHRLMNAPAMCES2 | |
| SCHEMBL667189 | 0.94 | CES1 (0.42) | DGKATSHRLMNAPAMCES2 | |
| SCHEMBL10889536 | 0.90 | DGKA (0.53) | DGKATSHRLMNAMAPTCNR2 | |
| SCHEMBL5930620 | 0.90 | DGKA (0.53) | DGKATSHRLMNAMAPTCNR2 | |
| SCHEMBL8812664 | 0.90 | DGKA (0.53) | DGKATSHRLMNAMAPTCNR2 | |
| SCHEMBL11266899 | 0.90 | DGKA (0.53) | DGKATSHRLMNAMAPTCNR2 | |
| SCHEMBL17440355 | 0.90 | DGKA (0.53) | DGKATSHRLMNAMAPTCNR2 | |
| SCHEMBL21956085 | 0.90 | DGKA (0.53) | DGKATSHRLMNAMAPTCNR2 | |
| SCHEMBL10892398 | 0.90 | DGKA (0.53) | DGKATSHRLMNAMAPTCNR2 | |
| SCHEMBL6438468 | 0.90 | DGKA (0.53) | DGKATSHRLMNAMAPTCNR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6897255-B1 | Latex compositions containing ethylenically unsaturated esters of long-chain alkenols and applications thereof | UNIVERSITY OF SOUTHERN MISSISSIPPI (US) | 2005-05-24 | — | — | US | disclosed |
| US-6700006-B2 | (METH)ACRYLATE ESTERS OF HYDROXY LONG-CHAIN OLEFINIC COMPOUNDS DERIVED FROM CASTOR OIL, FOR EXAMPLE; LATEX; WATERBORNE COATINGS, ADHESIVES, INKS; FORM WITHOUT USING VOLATILE ORGANIC COMPOUNDS (VOC'S) | UNIVERSITY OF SOUTHERN MISSISSIPPI | 2004-03-02 | — | — | US | disclosed |
| US-6653381-B2 | Copolymers of acrylate or methacrylate esters of hydroxy long-chain olefinic compounds derived from nondrying oils, e.g. castor oil or lesquerella oil preferred; latex films; waterbased paints, coatings, contact and pressure adhesives | UNIVERSITY OF SOUTHERN MISSISSIPPI | 2003-11-25 | — | — | US | disclosed |
| US-6624223-B1 | Crosslinkable copolymer comprising (meth)acrylated castor or lesquerella oil and ethylenically unsaturated monomers; cobalt, manganese, lead, zirconium, or calcium carboxylate drying agent; pressure sensitive adhesives, inks | UNIVERSITY OF SOUTHERN MISSISSIPPI | 2003-09-23 | — | — | US | disclosed |
| US-6599972-B2 | Water soluble; low volatility solvents; odorless | UNIVERSITY OF SOUTHERN MISSISSIPPI | 2003-07-29 | — | — | US | disclosed |
| US-20020007080-A1 | Novel internally plasticizing and crosslinkable monomers and applications thereof | UNIVERSITY OF SOUTHERN MISSISSIPPI | 2002-01-17 | — | — | US | disclosed |
| US-20010031883-A1 | Novel internally plasticizing and crosslinkable monomers and applications thereof | THE UNIVERSITY OF SOUTHERN MISSISSIPPI | 2001-10-18 | — | — | US | disclosed |
| US-20010021739-A1 | Latex compositions containing ethylenically unsaturated esters of fatty compounds and applications thereof | THE UNIVERSITY OF SOUTHERN MISSISSIPPI (US) | 2001-09-13 | — | — | US | disclosed |
| WO-2001044380-A2 | NOVEL INTERNALLY PLASTICIZED AND LOW VOC LATEX COMPOSITIONS AND APPLICATIONS THEREOF | THE UNIVERSITY OF SOUTHERN MISSISSIPPI (US) | 2001-06-21 | — | — | WO | disclosed |
| US-6235916-B1 | INCLUDE ACRYLATE OR METHACRYLATE ESTERS OF HYDROXY LONG-CHAIN OLEFINIC COMPOUNDS DERIVED FROM CASTOR OIL OR LESQUERELLA OIL. | UNIVERSITY OF SOUTHERN MISSISSIPPI | 2001-05-22 | — | — | US | disclosed |
| US-6001913-A | COATINGS, ADHESIVES AND INKS FROM BLENDS OF PLASTICIZING CROSSLINKABLE ALKENOL ESTER OF ETHYLENICALLY UNSATURATED CARBOXYLIC ACID MONOMER | THE UNIVERSITY OF SOUTHERN MISSISSIPPI | 1999-12-14 | — | — | US | disclosed |
| US-5827863-A | Pyrazole derivatives as angiotensin II antagonists | J. URIACH & CIA, S.A. (ES) | 1998-10-27 | — | — | US | disclosed |
| WO-1997041128-A1 | 3-PYRAZOLIOMETHYLCEPHEM COMPOUNDS AS ANTIMICROBIAL AGENTS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1997-11-06 | — | — | WO | disclosed |
| EP-0721454-A1 | NEW PYRAZOLE DERIVATIVES AS ANGIOTENSIN II ANTAGONIST | J. URIACH & CIA. S.A. (ES) | 1996-07-17 | — | — | EP | disclosed |
| WO-1996004273-A1 | NEW PYRAZOLE DERIVATIVES AS ANGIOTENSIN II ANTAGONIST | J. URIACH & CIA, S.A. (ES) | 1996-02-15 | — | — | WO | disclosed |
| EP-0307804-B1 | Cephem compound and a process for preparation thereof | FUJISAWA PHARMACEUTICAL CO (JP) | 1993-11-18 | — | — | EP | disclosed |
| US-5187160-A | CEPHEM COMPOUND | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1993-02-16 | — | — | US | disclosed |
| EP-0386689-A1 | New cephem compound and a process for preparation thereof | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1990-09-12 | — | — | EP | disclosed |
| US-4952578-A | Cephem compound and a process for preparation thereof | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1990-08-28 | — | — | US | disclosed |
| EP-0307804-A2 | Cephem compound and a process for preparation thereof | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1989-03-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020007080-A1 | Novel internally plasticizing and crosslinkable monomers and applications thereof | LATS2, LATS1, LTA | DGKA 543/4885TSHR 4031/4885LMNA 337/4885 |
| US-20010031883-A1 | Novel internally plasticizing and crosslinkable monomers and applications thereof | LATS2, LATS1, LTA | DGKA 543/4885TSHR 4031/4885LMNA 337/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.